FindTrial
Sign In

The clinical effect of low temperature radiofrequency ablation under contrast-enhanced ultrasound in the treatment of refractory hyperthyroidism

The clinical effect of low temperature radiofrequency ablation under contrast-enhanced ultrasound in the treatment of refractory hyperthyroidism

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800017199
Enrollment
Unknown
Registered
2018-07-17
Start date
2018-07-16
Completion date
Unknown
Last updated
2018-07-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hyperthyroidism

Interventions

Experimental group:low temperature radiofrequency ablation under contrast-enhanced ultrasound
Control group:Routine anti-thyroid medicine treatment

Sponsors

Beijing Luhe Hospital, Capital Medical Universtiy
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
21 Years to 75 Years

Inclusion criteria

Inclusion criteria: The diagnosis was consistent with Graves' hyperthyroidism, with a duration of more than 6 months; In the treatment process of anti-thyroid medication, the clinical symptoms are repeated more than twice a year and are difficult to control.Continuing goiter, II-III degree;Repeated abnormal thyroid function.

Exclusion criteria

Exclusion criteria: History of past malignant tumors; Parliamentary pregnancy or lactation period; Hepatorenal disease

Design outcomes

Primary

MeasureTime frame
Thyroid iodine uptake rate;—

Secondary

MeasureTime frame
Thyroid hormone assay;—

Countries

China

Contacts

Public ContactNing Zhang

Beijing Luhe Hospital, Capital Medical University

zning-1986@163.com+86 13601354101

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026